David Granger is currently the Vice President of R&D at NovalGen since September 2019. Prior to this role, David held positions such as Director of Discovery at NovalGen, Senior Scientist II at Crescendo Biologics Limited, Investigator and Programme Leader at GSK, and Postdoctoral Researcher at Imperial College London. David has a Ph.D. in Molecular Biology from Imperial College London, an M.Res. in Biological Sciences/Pharmacology from The University of Manchester, and a B.Sc. in Pharmacology from The University of Manchester.
This person is not in any teams